Home
GSC Advanced Research and Reviews
Peer-reviewed | Multidisciplinary Journal | Impact factor 8.3 | ISSN: 2582-4597 | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Mapping Normal and Abnormal Gonadotropins and Sex Steroids Across Puberty and When to Use Testosterone in CDGP: A 20-Year Mini-Review

Breadcrumb

  • Home
  • Mapping Normal and Abnormal Gonadotropins and Sex Steroids Across Puberty and When To Use Testosterone In CDGP: A 20-Year Mini-Review
  • Mapping Normal and Abnormal Gonadotropins and Sex Steroids Across Puberty and When to Use Testosterone in CDGP: A 20-Year Mini-Review

Ashraf Soliman 1, *, Nada Alaaraj 1, Fawzia Alyafei 1, Shayma Ahmed 1, Noora AlHumaidi 1, Noor Hamed 1, Shaymaa Elsayed 2 and Ahmed Elawwa 2

1 Department of Pediatrics, Hamad Medical Center, Doha, Qatar.
2 Alexandria University Children's Hospital, Alexandria, Egypt.
 
Research Article
GSC Advanced Research and Reviews, 2025, 25(01), 087-099.
Article DOI: 10.30574/gscarr.2025.25.1.0310
DOI url: https://doi.org/10.30574/gscarr.2025.25.1.0310
Received on 03 September 2025; revised on 11 October 2025; accepted on 14 October 2025
 
Background: Pubertal development is regulated by the activation of the hypothalamic–pituitary–gonadal (HPG) axis, resulting in progressive increases in gonadotropins and sex steroids. Accurate mapping of normal and abnormal hormone trajectories across puberty is essential for differentiating physiological from pathological pubertal patterns.
Objectives: To review normative data for gonadotropins and sex steroids across pubertal stages in boys and girls, define cut-off values for early pubertal onset (Tanner stage 2), and summarize their diagnostic applications.
Methods: We reviewed tabulated normative data from longitudinal and cross-sectional studies included in the provided manuscript. Hormone values were presented according to Tanner staging, and where available, cut-offs for Tanner stage 2 were identified.
Results: Across puberty, luteinizing hormone (LH), follicle-stimulating hormone (FSH), testosterone, and estradiol progressively increased with Tanner stage, with distinct male–female patterns.
·         Girls: Tanner stage 2 was defined by estradiol values ≥20 pg/mL, basal LH >0.3–0.6 IU/L, and peak LH >5–8 IU/L following GnRH stimulation.
·         Boys: Tanner stage 2 corresponded to testosterone 25–75 ng/dL, basal LH >0.3–0.6 IU/L, peak LH >5–8 IU/L after GnRH stimulation, and testicular volume 4–6 mL (measured by Prader orchidometer or ultrasound).
·         LH and FSH showed low baseline values in Tanner stage 1, with rapid increments at stage 2 and beyond. In boys, testosterone rose sharply from stage 2 onward, while in girls, estradiol increased more gradually, peaking at later stages.
·         Reference intervals for nine steroid hormones demonstrated sex-specific and age-related variations, with marked overlap between late prepuberty and early puberty for some markers.
·         The review confirmed that uterine length >35 mm and ovarian volume >2 mL in girls were supportive of pubertal onset, while testicular volume ≥4 mL in boys was a reliable marker of central puberty initiation.
Conclusion: Normative pubertal hormone reference ranges allow precise differentiation between normal and abnormal timing of puberty. Tanner stage 2 cut-off values—estradiol ≥20 pg/mL in girls, testosterone 25–75 ng/dL and testicular volume 4–6 mL in boys—provide clinically useful thresholds for identifying pubertal onset. Integration of hormonal stimulation and ultrasound parameters enhances diagnostic accuracy in distinguishing central precocious puberty, delayed puberty, and variants of normal development.
 
Puberty; Tanner stage; Gonadotropins; Sex steroids; Diagnostic cut-offs
 
https://gscarr.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCARR-2025-…

Preview Article PDF

Ashraf Soliman, Nada Alaaraj, Fawzia Alyafei, Shayma Ahmed, Noora AlHumaidi, Noor Hamed, Shaymaa Elsayed and Ahmed Elawwa. Mapping Normal and Abnormal Gonadotropins and Sex Steroids Across Puberty and When to Use Testosterone in CDGP: A 20-Year Mini-Review. GSC Advanced Research and Reviews, 2025, 25(1), 087-099. Article DOI: https://doi.org/10.30574/gscarr.2025.25.1.0310

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 GSC Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution